Mahindra University’s Centre for Life Sciences (CLS) invites admission for their M.Sc. by Research in BioTherapeutics Program (2026−27 Batch), commencing in the Fall Semester, July 2026. This specialized program is designed to cultivate the next generation of researchers and leaders in the rapidly evolving fields of biopharma, biomedical, and biotech. Our curriculum emphasizes a research-focused approach, culminating in a year-long dissertation.

Program Highlights:

• Research-Focused Curriculum: A year-long dissertation on novel biotherapeutic modalities.
• Advanced Lab Access: State-of-the-art facilities in gene/​cell therapy, nanobody engineering, bioprocessing, characterization, nanomedicine, and biosensors.
• Hands-On Training: Practical experience with industry-grade instrumentation and high-end bioanalytical tools.
• Exposure to Cutting-Edge Fields: Opportunities to explore genome editing, synthetic biology, and translational research.
• Mentorship by Global Experts: Guidance from leading academic institutions and biotech industries.
• Skill Integration: Development of skills in project design, scientific writing, data analysis, and delivery pipelines aligned with industry standards.

2 Years.

Select meritorious students may be eligible for a Teaching Assistantship, offering INR 18,000/- per month, or boarding & lodging, or both. Conditions apply.

B.Sc. (Biology/Non-Medical), B.Tech , 4 Year B.Sc., MBBS, BDS, B.Pharm, B.V.Sc.

Interested candidates can email pgadmissions@​mahindrauniversity.​edu.​in to obtain details of the application process.